Iron deficiency anaemia: who works on it

One card per institution. Pick a target or a country to narrow the list.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Sucrosomial Vs Intravenous Iron for Preoperative Anemia

  NCT07287371· University of Rochester· Updated 6 Oct 2026

  “Study withdrawn due to lack of funding and the company's decision not to pursue the IND. No participants were enrolled.”Registry text, quoted unchanged. Source

• Terminated

  IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches

  NCT07053475· Syed Hamza Mufarrih· Updated 20 Jul 2026

  “Post-discharge low follow-up (\<50%) rates.”Registry text, quoted unchanged. Source

• Withdrawn

  Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

  NCT04649411· Keryx Biopharmaceuticals· Updated 20 Nov 2025

  “PMR release”Registry text, quoted unchanged. Source

• Withdrawn

  Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

  NCT06508827· Indiana University· Updated 9 Jul 2025

  “Difficulty recruiting participants”Registry text, quoted unchanged. Source

• Terminated

  Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

  NCT04594070· The University of Texas Medical Branch, Galveston· Updated 24 Jun 2024

  “Unable to recruit enough participants”Registry text, quoted unchanged. Source

• Withdrawn

  A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).

  NCT05927012· Keros Therapeutics, Inc.· Updated 24 Nov 2023

  “Despite several attempts to recruit eligible participants and major protocol amendments to increase the recruitment rate, recruitment challenges remained. Therefore, the Sponsor has made the decision to terminate the KER047-IR-202 Study globally.”Registry text, quoted unchanged. Source

• Withdrawn

  Adherence of Iron Succinylate Therapy in Pregnancy

  NCT03873571· Elpen Pharmaceutical Co. Inc.· Updated 15 Feb 2023

  “Modification of clinical development plan”Registry text, quoted unchanged. Source

• Withdrawn

  Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

  NCT04968379· American Regent, Inc.· Updated 6 Jan 2023

  “Difficult to recruit and enroll patients for this study in a reasonable amount of time.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy

  NCT07366502· Medeni Şermet· Source

• Effect of Vitamin D Supplementation Added to Iron Therapy in Children With Iron Deficiency Anemia

  NCT07892170· AlFayhaa General Hospital· Source

• Co-administration of Calcium and Multiple Micronutrient Supplements for Maternal and Newborn Hemoglobin and Iron Status

  NCT06568315· Johns Hopkins Bloomberg School of Public Health· Source

• Liposomal Iron Versus Ferrous Iron Supplementation for Early Prophylaxis of Iron Deficiency Anemia in Preterm Neonates

  NCT07667205· Ain Shams University· Source

• Different Efficacy of IFA Supplementation Among Obese and Non-obese Women

  NCT06622551· Griffith University· Source

• FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized Communities

  NCT07633262· Cairo University· Source

• Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

  NCT05340465· University of Washington· Source

• Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

  NCT06884280· Hull University Teaching Hospitals NHS Trust· Source

• Bevacizumab In Hereditary Hemorrhagic Telangiectasia

  NCT04404881· Hanny Al-Samkari, MD· Source

• Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia

  NCT07563582· Istituto Giannina Gaslini· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.